Clinical Trial 40239

share

Long Beach, CA 90806


Study Summary:

Open-label Study of Safety and Tolerability of Chronic
Intermittent Usage for 24 or 52 Weeks of Intranasal
Dihydroergotamine Mesylate (DHE) Administered using
the I123 Precision Olfactory Delivery (POD®) Device
[INP104, POD-DHE] in Patients with Migraine Headache


Qualified Participants Must:

• Adult males and females, 18 to 65 years of age
• Must have documented diagnosis of migraine


Qualified Participants May Receive:

Compensation for time and travel 


Research Site Profile

View Clinic Profile


Study is Available At:

CNS Network
2600 Redondo Ave.
Long Beach, CA 90806
View Clinic Location

 


If you would like to get the phone number or be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.